Imatinib

Imatinib is a medication classified as an anti-cancer medicine. It is commonly prescribed for treating specific types of blood cancer, such as chronic myeloid leukaemia, as well as cancers of the stomach and intestines. This medicine works by slowing or halting the growth of abnormal cancer cells, helping to control the spread of the disease. While taking Imatinib, some individuals may experience side effects. The most common include nausea, vomiting, swelling (oedema), diarrhoea, muscle cramps, fatigue, abdominal pain, and skin rashes. These effects are typically manageable, but you should always inform your doctor if they become severe or troublesome. A warning sign to watch for is sudden or rapid weight gain, which should be reported immediately to your doctor as it may indicate fluid retention. It is important to take Imatinib exactly as prescribed by your doctor. Swallow it with a glass of water, preferably with a meal to minimise stomach upset. Do not stop or skip doses on your own, as this may decrease the treatment's effectiveness. If you experience dizziness or blurred vision, avoid driving or operating machinery until you feel better. Before beginning treatment, inform your doctor of your complete medical history, including conditions such as liver, kidney, or heart problems, thyroid disorders, or if you have had your thyroid gland removed. Also, if you have ever had hepatitis B infection, mention this to your doctor because the medication can sometimes reactivate the virus. Your doctor may recommend regular blood tests to monitor your response and detect any potential side effects. While using Imatinib, always be vigilant for warning signs such as easy bruising, bleeding, fever, extreme tiredness, or confusion. These may indicate changes in your blood cells and should be reported promptly to your healthcare provider. Following your doctor's instructions carefully, maintaining a healthy diet, and attending regular follow-up appointments will help you achieve the best results from your treatment while reducing risks.